Cannabis Freedom Index

Changelog 901f46b

Fill Gibraltar history gap and correct drug-law profile

9 history entries added4 history entries edited1 country profile edited4 articles written1 article edited1 file of code, design or docs +942 −146 lines

History changes.yaml

Added 9

Edited 4

Gibraltar lets public health doctors supply cannabis-based medicines

description

The Drugs (Misuse) (Amendment) Regulations 2019 allowed trained doctors of theTrained Gibraltar Health Authority to supplydoctors could authorise approved cannabis-based productsmedicines from 16 October 2019 for four groups of conditions that had resisted standard treatment.[@1, dispensed only by2] Patients could lawfully hold medicines supplied through that route, with smoking prohibited; the hospitalgovernment designated St Bernard’s Hospital pharmacy for public dispensing.[@1,2] In September 2023 the government announced completed doctor training and nota supply agreement with Cantourage UK, subject to be smokedfinal detail.[@3]

sources

Medicinal cannabis products to be available to GHA patients — 614/2023 2 unchanged

tags

patients

related

gibraltar-sativex-regulations-2017, gibraltar-medicinal-cannabis-act-2021, gibraltar-medicinal-cannabis-supply-agreement-2023, gibraltar-drug-code-replacement-2012

Gibraltar creates a controlled medicines route for Sativex

description

LN 25/2017 moved aA precisely defined cannabis-extract mouth spray moved from Schedule 1the most restricted drug schedule into Schedule 2 of the Drugs (Misuse) Regulationscontrolled-medicines schedule on 15 February 2017. Its[@1] The government’s explanatory memorandum identified Sativex and access through the medicines framework. This narrow change took effect on publication;route through which it did not authorise generalcould be supplied.[@1] Wider rules for GHA-approved cannabis possession or cultivationmedicines followed in 2019.[@2]

sources

Drugs (Misuse) (Amendment) Regulations 2019 1 unchanged

tags

patients

unscored

A narrow pharmaceutical route; the existing access step remains at the wider 2019 GHA patient rules because operating Sativex availability was not established.

Gibraltar approves a medicinal cannabis industry licensing law

title

Gibraltar assents toapproves a medicinal cannabis industry licensing Act awaiting commencementlaw

description

The Medicinal Cannabis Act 2021 received assent with provisionsGibraltar approved a law for a commission and licences covering medicinal cannabis production, import, export, marketing and supply for medicinal purposeson 24 September 2021. Section 2[@1] Starting the law requires commencement bya ministerial notice. The, and the official text remainsremained marked Not In Force when checked on 2024 October 2026.[@1] The existing GHA patient rules continued separately, so assent is recorded here rather than the opening of an operational licensing systemfollowed by a 2023 supply announcement.[@2,3]

sources

Drugs (Misuse) (Amendment) Regulations 2019 Medicinal cannabis products to be available to GHA patients — 614/2023 1 unchanged

tags

patients, trade

unscored

Assent to a law awaiting commencement; its wider industry licensing system has not started.

Gibraltar announces trained cannabis doctors and a supply agreement

title

Gibraltar announces a medicinaltrained cannabis doctors and a supply agreement after doctor training

description

The government announced that GHA doctors had completed the requirednecessary training and that agreementthe government had been reached an agreement with Cantourage UK, subject to final detail, to allowenable cannabis prescribing for eligible patients with certain conditions.[@1] The release documents an implementation step afterSeptember 2023 announcement followed the 2019 regulations; it does not establish the first dispensing date or the number of patients receivingrules requiring trained public doctors and specifically approved products.[@1,2] Health minister John Cortes said the government had been working to make these medicines available for some time.[@1]

sources

Drugs (Misuse) (Amendment) Regulations 2019 1 unchanged

tags

patients, trade

unscored

A supply arrangement and training milestone under the existing 2019 access rules; no new prescribing entitlement or first dispensing date was established.

Countries and states 1 file

Gibraltar countries/gi.yaml

summary

Cannabis is a Class B drug and possession is prosecuted in the Magistrates' Courtand home growing are crimes, where it ends in a fine. Smuggling cannabis resin by sea is punished with years in prisonfines or imprisonment available. Since 2019 doctors at theMedical access is limited to controlled medicines: trained public-health authoritydoctors may supplyauthorise approved cannabis-based medicines that are not smokedproducts for specified conditions, with smoking prohibited.

segments › possession › text

Possession of cannabis, aCannabis and resin are Class B drugdrugs. Possession can bring up to twelve months in prison or a fine in lower-court proceedings, isor five years or a criminal offence triedfine in the Magistrates' Courta higher-court trial.[@law] In December 2025 a man stopped on a foot patrolfound with about 127 g of cannabis resin was charged with possession and finedreceived an £800 therefine in the day after his arrestMagistrates’ Court.[@police]

segments › possession › sources

rgp25law, police

segments › cultivation › text

GrowingCultivating any cannabis plant is production ofan offence, subject to authorised exceptions. The cultivation offence carries up to nine months in lower-court proceedings or fourteen years in a controlled drug under the Drugs (Misuse) Acthigher-court trial, with no exception for personal usefines also available. No licensed cultivation exists[@law] The wider medicinal-cannabis industry Act remains awaiting commencement.[@m21]

segments › cultivation › sources

gov19law, m21

segments › enforcement › text

Possession cases end inCourts can impose fines in the Magistrates' Court. Smuggling is punished withor prison: in July 2026 for possession; the Supreme Court jailed two men caughtstatutory maxima depend on a boat from Ceuta with 284how the case is tried.5 kg[@law] One December 2025 possession case involving about 127 g of cannabis resin for four years and for three years and five monthsended in an £800 fine.[@police] A separate reported possession-with-intent-to-supply case ended in 200 hours of community work.[@supply]

segments › enforcement › sources

rgp25law, chr26police, supply

segments › sharing › text

Possession with intentSupplying or offering to supply cannabis is prosecuted as a separatean offence: a 19-year-old with cannabis resin worth £1,180 hidden with no payment requirement in the prohibition. Class B supply or possession with intent to supply can carry up to life imprisonment in a sofa was given 200 hours of unpaid community workhigher-court trial; fines are also available. No distinction is made for sharing without payment.[@law]

segments › sharing › sources

rgp652law

segments › consumption › text

Use is dealt with through theUnauthorised possession offenceassociated with cannabis use is criminal. Even patientsOccupiers who knowingly permit cannabis smoking on their premises can also commit an offence.[@law] Patients using approved GHA cannabis medicinesproducts may not takeadminister them by smoking.[@reg]

segments › consumption › sources

gov19law, reg

segments › access › text

No legal adultAdult-use sourcesupply is prohibited. Since 2019[@law] The medical route requires trained GHA doctors working for the Gibraltar Health Authority, after training, may supplyand approved cannabis-based products for fourspecified conditions: spasticity in multiple sclerosis, severe refractory epilepsy, severe pain that has not responded to standard treatment, and nausea from chemotherapy. They are dispensed only by; the hospitalgovernment designated St Bernard’s Hospital pharmacy for public dispensing.[@gov19] In September 2023 it announced completed training and a Cantourage UK supply agreement, subject to final detail.[@gov23]

segments › access › sources

law, gov19, gov23

context › production › text

No licensed cannabisUnauthorised production. Cannabis resin arrives by sea is criminal, and the courts treat large importations severelycultivating cannabis has its own offence.[@law] The 2021 medicinal-cannabis Act provides for a wider industry licensing system but is still marked Not In Force; commencement requires a ministerial notice.[@m21]

context › production › sources

chr26law, m21

context › products › text

OnlyThe rules distinguish the specifically defined cannabis-extract mouth spray in Schedule 2 from GHA-approved cannabis-based medicines approved by the Gibraltar Health Authority as safein Schedule 2A. The latter require medical-practitioner involvement and effective, supplied throughproduct approval.[@reg] Public dispensing under the pharmacy atGHA route was assigned to St Bernard'’s Hospital pharmacy. Products already sold in local pharmacies were not affected by the 2019 rules.[@gov19]

context › products › sources

reg, gov19

context › medical › text

The Drugs (Misuse) (Amendment) Regulations 2019 let trainedGHA doctors of the public health authority supplymust complete training before authorising cannabis medicines. Eligible conditions are treatment-based products for medicinal use in limited circumstancesresistant multiple-sclerosis spasticity, severe refractory epilepsy, severe life-altering pain, and intractable chemotherapy-related nausea and vomiting. Each product needs the authority'sProducts require GHA approval, and patients may not smoke themsmoking is prohibited.[@reg] The government reported completed doctor training and a supply agreement in September 2023.[@gov23]

context › medical › sources

gov19reg, gov23

context › consequences › text

A possession case leavesPossession can lead to a criminal conviction. Seized drugs are forfeited andfine, in importation casesimprisonment or both, depending on the vessel too, and confiscation proceedings may followand sentence.[@law] Courts can order forfeiture and destruction or disposal of items connected with drug offences.[@law]

context › consequences › sources

rgp25, chr26law

context › clubs › text

NoSupplying cannabis clubsto another person and cultivating it are knownoffences, subject to authorised exceptions. Supply is prosecutedThe criminal code provides no personal-use club exemption.[@law]

context › clubs › sources

rgp652law

context › visitors › text

There is no legal supply for anyone, and importingAdult-use cannabis is prosecuted in the Supreme Courtimports are prohibited; authorised imports depend on a licence or a regulatory exception.[@law] The medicines regulations allow personal prescribed controlled drugs to be carried to or from a Schengen state with prison sentencesa valid Article 75 certificate, limited to thirty days’ supply.[@reg]

context › visitors › sources

rgp25law, reg

sources

Crimes Act 2011 — current consolidated edition Drugs (Misuse) Regulations 2005 — current consolidated edition Medicinal Cannabis Act 2021 Medicinal cannabis products to be available to GHA patients — 614/2023 Gibraltar Chronicle — Two men jailed for importing cannabis worth £1.4m (27 July 2026) 3 unchanged

Articles and atlas entries 5

gibraltar-medicinal-cannabis-regulations-2019 articles/gibraltar-medicinal-cannabis-regulations-2019.md

text

Gibraltar's 2019 regulations created authorised a limitedwider route forto cannabis-based medicines through its public health service. The legal change took effect on 16 October, when the regulations were published in the gazette 2019. The government's explanatory announcement followed on 22 October. That distinction matters in a timeline: the announcement describes the policyTrained Gibraltar Health Authority doctors could authorise approved products for specified conditions, but the original instrument supplies its commencement date and eligible patients could lawfully possess medicines supplied through that route.[@2] ## An earlier route for aA mouth spray came first The [February 2017 amendmentchange](/history/gibraltar-sativex-regulations-2017/) had already mademoved a narrower change. It placed a precisely specified cannabis-extract, delivered as a metered mucosal mouth spray, in Schedule 2 of into the drug regulationscontrolled-medicines schedule. TheIts explanatory memorandum identified Sativex and described access under the framework governing medicines. This was a product-specific exception. It should not rules through which it could be read as an opening for all cannabis products or as permission to grow cannabis at homesupplied. ## Access through trained public doctors[@1] The 2019 schemeregulations added a separate category for approved cannabis-based products for medicinal use approved by the GHA. PractitionersActing Medical Director Dr Krishna Rawal described the initiative as a way to give patients more treatment options when existing medication had failed.[@2,3] ## Public doctors needed training and approved products Doctors had to be registered doctorsmedical practitioners employed by the Gibraltar Health Authority who had completed the relevant GHA and complete training in the use of these products. Products Each medicine required the GHA’s specific approval afteras safe and effective, following consultation with thosethe authorised practitioners.[@2,3] The government explained that public dispensing would be confined todesignated the GHA pharmacy at St. Bernard'’s Hospital for supply to the public. Existing productsProducts already obtainable throughfrom local pharmacies would retainretained their availability.[@3] For a patient, lawful possession depended on a qualifying diagnosis and a medicine supplied by, or under the direction of, an authorised cannabis practitioner. The regulations also imposed conditions concerning disclosure of other controlled medicines and truthful information when obtaining supply.[@2] ## Four groups of conditions qualified The regulations listed treatment-resistantrules covered moderate to severe multiple-sclerosis spasticity, severe refractory epilepsy, severe life-altering pain, and intractable chemotherapy-related nausea and vomiting, each associated with qualificationschemotherapy. Each category included requirements concerning unsuccessfulfailure of standard treatment. Patient possession depended on diagnosis and supply by, or under the direction of, an authorised practitioner.[@2] The instrument alsoregulations expressly prohibited administering thethese cannabis products by smoking. The Patients’ permission was tied to medicaltheir treatment and specified products, rather than a general personal-use exemptionthe approved supply route.[@2] ## LegislationTraining and implementation followed different pathssupply took further work The [Medicinal Cannabis Act 2021 medicinal-cannabis industry law](/history/gibraltar-medicinal-cannabis-act-2021/) received assent on 24 September. It set out a broader licensing architecture coveringcommission and wider production, import, export, marketing and supply. Its commencementtrade licences, however, depended on but commencement required a ministerial notice. The official text remained marked “Not In Force” when checked on 20in October 2026. A separate [@4] In [September 2023 announcement](/history/gibraltar-medicinal-cannabis-supply-agreement-2023/) reported, the government announced that GHA doctors had completed doctor training and anthat agreement had been reached with Cantourage UK, subject to final detail, to enable prescribing. Health minister John Cortes said work to make these products available had been under way for eligible patientssome time. It did not identify a first dispensing date or patient totals. Together[@5] For patients, these records givethe rules linked access to trained public doctors, qualifying conditions and approved medicines. Those requirements sit alongside the possession and supply offences described in [Gibraltar'’s historycurrent profile](/country/gi/) several distinct milestones: a narrow medicine exception, a wider patient framework, an uncommenced industry statute and a later supply arrangement. Treating each as the same moment would obscure what patients and prospective producers could actually do.

Code, design and documents 1 file

docs/research/history-gibraltar-gap-2026-10-24.md +62 −0
@@ -0,0 +1,62 @@
+# Gibraltar history gap and profile audit — 24 October 2026
+
+## Changes
+
+Nine new events fill the largely empty period before the existing medical reforms: the October 1951 possession rules, September 1960 rule-making amendment, June 1973 drug statute, December 1985 overseas-recipient wording, August 1989 supply presumption, March 1995 ship powers, June 1995 Harris judgment, November 2012 replacement code, and December 2025 possession sentence. Four medical events were revised for clearer wording, inline citations, tags and explicit unscored reasons where appropriate. Their IDs and existing dates were preserved.
+
+Four articles were added (1951, 1989, Harris, 2012); the existing 2019 medical article was rewritten. All five have four headings, 350–500 words, inline source marks, history links and a country link. The profile's twelve text blocks now use keyed inline citations. Its former claims that possession cases universally end in fines, no cultivation licences exist, and visitors have no lawful import exception were replaced with the actual statute, regulatory exceptions and individual case outcomes.
+
+Current scores, medical status and recreational status are preserved. Exact score **12**. The chain remains estimated 100 → 11, then 2019 access 0 → 1 giving 12. No representative national sentencing series was found to justify a numerical enforcement change. Statutory maxima and isolated fines are described separately. A maximum increase within an already criminal regime does not, by itself, prove a move to routine imprisonment.
+
+## Evidence and source boundaries
+
+Downloads, text extractions, selected page images, scripts and build logs are retained in `tmp/history-gibraltar-gap-2026-10-24/`. Sources were read directly, with the following scope; downloading a large consolidation does not mean every unrelated criminal offence was read.
+
+### Colonial controls and first restriction
+
+- UN **E/NL.1951/37**, two pages: read the March 1951 amendment, including Governor Kenneth Anderson's assent on 15 March, new section 4A and the one-month/£150 ceiling. This is an enabling power, not itself the October possession rule.
+- UN **E/NL.1952/2–3**, three pages: read the possession rules on p. 2, made **18 October 1951**, and checked the page image. The instrument title refers to raw opium but rule 2 also expressly covers Indian hemp and coca leaves. It provides a fine **or** prison, and possession through another person's control or holding. The unrelated third-page order schedules other drugs. The public event uses the rule-making date; a separate gazette publication/commencement day was not recovered.
+- UN **E/NL.1960/106**, one page: read the complete amendment deleting section 4A(2). Assent **22 September**, gazette publication **23 September 1960**. The event explicitly describes publication. Removal of the enabling-law penalty ceiling is not assumed to have rewritten the 1951 rule's own fine/prison limits automatically.
+- The existing first-restriction estimate stays unchanged. These sources prove an express 1951 possession offence, but do not establish the first import, medicinal or trade control. The 1951 enabling law refers to the 1935 revised edition of an earlier Dangerous Drugs Ordinance. A League-era catalogue lead points to a 1937 order, but its actual text was not recovered. The estimate therefore must not be replaced with an unsupported first-ever date.
+
+### The drug Act and its amendments
+
+- Official **1973 Act final consolidated edition**: read commencement/amendment and renumbering tables, definitions and relevant possession, production, supply, cultivation, quantity presumption, punishment and sentencing-table clauses. Verified **1 June 1973** commencement and **23 November 2012** repeal. The website labels its sole version 1 June 1973, but its download incorporates later amendments through 2007. The public entry limits the original-date description to the underlying separate offences (sections 6–7 and the renumbered cultivation clause), and dates later additions separately. It does not backdate the final quantity presumption or maritime powers to 1973.
+- Original **1985-20**, both pages: adds supply wording addressing a recipient outside Gibraltar. Effective date 5 December matches the principal Act's amendment table. Its intended effect and limits are explained using Harris, rather than assuming it created jurisdiction over all foreign transactions.
+- Original **1989-27**, all three pages: new section 7B, 20 g cannabis/resin commercial quantity, rebuttable presumption, mixtures/preparations and no-physical-possession rule. Date **10 August 1989** matches the principal Act table. It later became section 9 through renumbering. The amount is an evidential trigger, not lawful possession.
+- Original **1995-05**, relevant new sections 11C–11F and enforcement Schedule 5 read, with the amendment's commencement clause and principal Act table. Maritime provisions commenced **10 March 1995**, later than assent 1 March and publication 2 March. Other parts had separate commencement, including the precursor-regulation section in 1999; the maritime event does not backdate those parts. Authority/consent restrictions for another state's ship and territorial waters are retained in the description.
+- Original **1998-46** read: changes the official responsible for analysis certificates; omitted as an administrative change with little cannabis-history value.
+- Original **2004-02** read: Schengen-related changes, impossible attempts and precursors. No separate public event added; it does not show that every traveller provision began then.
+- **1991-15** original amendment also read where relevant to drug penalty changes. Section 36 changes “14 years” to life in **column 4** for production/supply/intent rows. The final old consolidation prints life in both Class A and B columns. Without the original earlier sentencing table and complete amendment reconstruction, the public history does not attribute a new Class B life maximum to that 1991 wording or to 1973. The 2012 and current code tables independently and clearly print life in the Class B production/supply/intent rows.
+
+### Harris: decision date versus report volume
+
+The official report **1997–98 Gib LR 11–23** actually states a judgment date of **1 June 1995**. Read headnote, facts and relevant judicial reasons, including the distinction between recipient location and intended supply location. Harris carried 737 g resin in 140 swallowed packets from Spain through Gibraltar to England. After arrest in England and later surrender in Gibraltar, he admitted possession/import/export but contested the additional intent-to-supply count. All three judges dismissed the Crown appeal. This was not a general acquittal of every cannabis offence.
+
+The court recounts Stanley's earlier airport cannabis case and the legislature's attempted response in 1985. Stanley's original judgment was not retrieved; no separate event with an invented decision date was added. The Harris event and article accurately attribute that background to the later court's account.
+
+### Replacement code and current law
+
+- Downloaded the actual historical **Crimes Act version at 23 November 2012**, distinct from the current download. Read the commencement table, relevant Part 21 clauses, sections 524 and 599, cannabis listing and Schedule 8. The old drug Act was repealed; drug regulations continued. No commercial-quantity presumption appears in the new Part 21. This is established through comparison with the repealed law, not merely a missing search result: the replacement's complete relevant drug-offence sequence was read.
+- Compared old Class B possession row (six months summary/five years indictment) with new row (twelve months summary/five years indictment), both fine/custody sentencing tables. Visually checked historical 2012 PDF p. 476. No claim is made that twelve months is a typical possession sentence.
+- Read new section 505: adults supplying on/near schools at relevant times or using couriers under eighteen; the court must treat these as aggravating and say so in open court. This is a mixed reform with the omission of the presumption, so category **other**, with an explicit unscored explanation.
+- Current **Crimes Act version 23 July 2026**, selected relevant sections 500, 503–508, 518, 524–526, Schedule 5 cannabis listing and Schedule 8. Verified current Class B possession up to twelve months summary or five years indictment; cultivation-specific offence nine months/fourteen years; Class B supply/intent statutory maximum life on indictment. The separate production offence also has its own sentencing entry. The cultivation and production rows must not be conflated.
+- Section 518 concerns occupiers/managers knowingly permitting cannabis smoking. It must not be confused with section 519's separate personal-use offence for prepared opium. No new cannabis-consumption offence was inferred from the opium section.
+- Royal Gibraltar Police **22 December 2025** report: actual court sentence **19 December**, arrest **18 December**, approximately 127 g resin and **£800 fine**. Event uses the sentence day. The report supports that one outcome, not universal fine-only practice.
+- Royal Gibraltar Police supply-case report: nineteen-year-old Sean Macmichael, cannabis resin found in sofa, possession/intent-to-supply, 200 hours community work. Used as an individual profile observation; the visible article lacks a reliable court-date field, so no separately dated history event was invented.
+
+### Medical rules and visitors
+
+- Original 2019 amending regulations read, including definitions, trained GHA practitioner, product approval, patient possession conditions, no smoking, four condition groups and schedules. Verified commencement **16 October 2019**. Government's **22 October** explanation and **8 September 2023** training/Cantourage announcement read in full relevant body. No first dispensing date or patient total is established by the 2023 release.
+- Current **2005 regulations**, 64-page consolidation through **15 October 2026**: relevant definitions, general licensing, regulations 10A/12A, medicine schedules, import/export and traveller provisions read. The new 2026 pharmacist/paramedic rules were checked; they do not replace the GHA-only Schedule 2A practitioner route. Pharmacist prescribing is confined to Schedules 4/5, and the paramedic list names other medicines. No broad cannabis-prescriber expansion was added.
+- **Regulation 31** is broader than a Schedule 2/3-only exception: it permits possession and travel to/from a Schengen state with a valid Article 75 certificate, personal prescribed quantity limited to **thirty days**. The profile records the statutory certificate route; it does not say any foreign prescription alone suffices, and no claim is made that the traveller is restricted by a schedule limitation absent from this clause.
+- 2021 industry Act's first page still says **Not In Force**, checked 24 October 2026; relevant commencement and licensing/commission clauses read. It remains an assent milestone, separate from the operating legal authority of the 2019 medicines regulations.
+- The existing 2017 source and account were retained for the narrow Sativex rescheduling; no new availability claim was added. Neither the 2017 event nor the 2023 supply announcement is newly assigned a score. The existing 2019 access score is preserved, and the date of actual first patient supply remains a research gap.
+
+## Verification and ownership
+
+The verifier checks unique IDs, categories, valid tags, readable title lengths, source coverage for all inline references, related/history/country links, article word counts and heading counts, all twelve country citation blocks, and unchanged pre-existing score vectors/current statuses. Five articles have 390–406 words and four headings each. `data-status.cjs chain gi` reports no flagged steps.
+
+A fresh production build and rendered checks verify the thirteen affected history pages (including all five article bodies), country reference scopes, tag pages, exports and profile API. Results and build cleanup are appended after completion. The commit is restricted to these nine added/four revised history objects, Gibraltar's profile, five article files and this memo. A private index isolates the commit while preserving other staged and working changes; `source-archive.json` is excluded.
+
+Final results: fresh production build passed with **3,954 pages**. Rendered verification passed **141 citation links**, all affected event/article and country reference scopes, tag pages, clean history/score exports, profile API date 2026-10-24, exact score 12 and unchanged Limited medical status. All five articles passed word-count, heading, citation and internal-link checks; whitespace checks passed. The owned temporary `site/` build was deleted after these checks. Research downloads, extraction files, selected images and logs were retained.

    ↑↓ to move, ↵ to open.